There is nothing offensive. It is another old topic. This company is a clinical stage company. They don't need to report the progress of research phase projects if there are no good results to report. I believe they should answer enquiries if this question was raised on AGM, but their answer cannot be satisfiable too, because they may have nothing to notify us now.
Ann: ATH Annual General Meeting Presentation, page-12
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $800 | 266.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 77 | 109919686 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 35572402 | 2 |
View Market Depth
| Last trade - 11.09am 11/11/2024 (20 minute delay) ? |
| ATH (ASX) Chart |